UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000021526 |
|---|---|
| Receipt number | R000024550 |
| Scientific Title | Phase I study of third-line FOLFIRINOX (oxaliplatin, irinotecan, 5-FU, and leucovorin) unresectable Gem/S-1 refractory pancreatic adenocarcinoma |
| Date of disclosure of the study information | 2016/03/18 |
| Last modified on | 2016/04/01 08:54:12 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/03/18 11:01:10 | ||
| 2 | Update | 2016/04/01 08:50:19 | Primary outcomes Primary outcomes |
|
| 3 | Update | 2016/04/01 08:54:12 | Name of primary person or sponsor Organization |
